Vendor, Berkeley, CA
Hopo Therapeutics, Inc.
UEI H5MWN5ZBXQ98, CAGE 8L3L6
1 award and $14,209,253 obligated between September 27, 2024 and April 27, 2026, 100% under full and open competition, against 1.0 offers on average where reported. 1 of the awards trace back to a SAM.gov solicitation on this site.
Sells to
Awarding agencies by dollars.
| Office of Assistant Secretary for Preparedness and Response | $14,209,253 |
Industries
NAICS on the awards, by dollars.
| Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)NAICS 541715 | $14,209,253 |
How it wins
Awards by competition, set-aside and type.
| Full and Open Competition | 1 |
| Definitive Contract | 1 |
Solicitations it won
SAM.gov opportunities whose award USAspending attributes to this vendor.
- Development of the Actinide Decorporation Agent HOPO-101 for Broad Spectrum Heavy Metal Exposure
Office of Assistant Secretary for Preparedness and Response, Barda - Aspr / Daappo / Barda DCMA
Award noticeNAICS 541714Berkeley, MO75A50124C00062Awarded to Hopo Therapeutics, Inc. for $226,309,811
Posted Oct 7, 2024
Awards
Every award in the window, by dollars obligated.
| Contract | Awarding office | Described as | Obligated |
|---|---|---|---|
| 75A50124C00062Definitive Contract, September 27, 2024, Full and Open Competition, 1 offersSolicitation | Barda - Aspr / Daappo / Barda DCMAOffice of Assistant Secretary for Preparedness and Response | Development of Hopo-101 as an MCM (Medical Countermeasure) Decorporation Agent for the Treatment of Individuals with Known or Suspected InteNAICS 541715, PSC Q701 | $14,209,253 |
- Places of performance
- California
- Product and service codes
- Q701 Specialized Medical Support
- Transactions
- 5 across 1 awards